Enovis Corporation

Enovis Corporation

ENOV·NYSE

$21.56

-1.7%
HealthcareMedical - Devices

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

At a Glance

Live Snapshot
Market Cap$1.24B
EPS-20.8600
P/E Ratio-1.03
Earnings Date08/06/2026

enov

Total Current Liabilities

Last Annual Value

598.47M

3-Year CAGR

2%

5-Year CAGR

-6%

10-Year CAGR

-6%

Enovis Corporation

Enovis Corporation Competitors Analysis of Total Current Liabilities

ENOV · NYSE
CompanyTotal Current Liabilities
CAGR 3Y
CAGR 5Y
CAGR 10Y
598.47M
17.4%-10.2%-6.0% 
ITT logo
ITT Inc.
NYSE:ITT
1.30B
7.8%6.9%4.1%
98.20M
14.9%3.2%6.2%
137.10M
-2.5%0.3%-5.5%
512.40M
8.1%4.6%1.9%
98.61M
-0.7%13.5%7.2%
KAI logo
Kadant Inc.
NYSE:KAI
53.36M
-37.1%-24.8%8.4%
757.20M
0.0%4.5%3.4%
344.05M
6.2%-2.8%8.1%
OFLX logo
Omega Flex, Inc.
NASDAQ:OFLX
15.96M
-4.1%-6.9%-3.5%
136.15M
4.8%18.0%15.6%
Enovis Corporation

Enovis Corporation Fair Value Envelope

ENOV · NYSE

Our analysis suggests that ENOV has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $21.56, this represents a potential HIDDEN relative to our calculated worth for Enovis Corporation.

Intrinsic Value
Current Price: $21.56